Thwarting resistance: MgrA inhibition with methylophiopogonanone a unveils a new battlefront against S. aureus.
Xuerui GuoLi WangJinlong ZhangQuan LiuBingmei WangDa LiuFei GaoGongga LanziYicheng ZhaoYan ShiPublished in: NPJ biofilms and microbiomes (2024)
Limitations in the clinical treatment of Staphylococcus aureus (S. aureus) infections have arisen due to the advent of antibiotic-resistant strains. Given the immense potential of therapeutic strategies targeting bacterial virulence, the role of MgrA as a pivotal virulence determinant in S. aureus-orchestrating resistance, adherence, and hundreds of virulence targets-becomes indispensable. In this investigation, leveraging advanced virtual screening and fluorescence anisotropy assays, we discerned methylophiopogonanone A (Mo-A), a flavonoid derivative, as a potent disruptor of the MgrA-DNA interaction nexus. Subsequent analysis revealed that Mo-A effectively inhibits the expression of virulence factors such as Hla and Pvl in S. aureus and markedly reduces its adhesion capability to fibrinogen. On a cellular landscape, Mo-A exerts a mitigating influence on the deleterious effects inflicted by S. aureus USA300 on A549 cells. Furthermore, our data indicate that Mo-A downregulates the transcription of genes associated with immune evasion, such as nucleases (nuc), Staphylococcal Chemotaxis Inhibitory Protein (chips), and Staphylococcal Complement Inhibitor (scin), thereby undermining immune escape and amplifying neutrophil chemotaxis. Upon application in an in vivo setting, Mo-A assumes a protective persona in a murine model of S. aureus USA300-induced pneumonia and demonstrates efficacy in the Galleria mellonella infection model. Of note, S. aureus displayed no swift acquisition of resistance to Mo-A, and the effect was synergistically enhanced when used in combination with vancomycin. Our findings add substantive weight to the expanding field of virulence-targeted therapeutic strategies and set the stage for more comprehensive exploration of Mo-A potential in combating antibiotic-resistant S. aureus.
Keyphrases
- staphylococcus aureus
- biofilm formation
- escherichia coli
- pseudomonas aeruginosa
- methicillin resistant staphylococcus aureus
- antimicrobial resistance
- single cell
- induced apoptosis
- poor prognosis
- cancer therapy
- metabolic syndrome
- oxidative stress
- weight loss
- endothelial cells
- transcription factor
- high throughput
- drug delivery
- type diabetes
- single molecule
- candida albicans
- high glucose
- long non coding rna
- body mass index
- weight gain
- cell proliferation
- big data
- climate change
- deep learning
- nucleic acid